โ† All deals

Rejuvenate Bio, Inc.

CrowdfundingBiotechnologyGene TherapyAging
๐Ÿ“ San Diego, CA, USโ€ข Founded 2019
StreetZero Signal 66
Be the first to signal interest

About Rejuvenate Bio, Inc.

Rejuvenate Bio, Inc. is a biotechnology company focused on pioneering gene therapy solutions to combat chronic diseases and the root causes of aging. The San Diego-based firm develops one-time gene therapies targeting aging and chronic conditions. Founded in 2019, it operates as a privately held company with a website at www.rejuvenatebio.com.

LATEST FUNDINGCrowdfunding
$5.0M
Announced 2026-11-02
TOTAL RAISED$28.57M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Rejuvenate Bio, Inc..

Free plan includes 3 full deal profiles every month.

Key highlights

  • Raised over $10M in Series A led by Kendall Capital Partners with participation from KdT Ventures and others.
  • Completed a $5M crowdfunding round with investors not disclosed.
  • Total funding across rounds exceeds $28M from institutional and other backers.
  • Developing gene therapies targeting chronic diseases and aging mechanisms.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account